These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 13716755)

  • 21. [A calcium-like effect of phenylbutazone (butazolidin)].
    BAUST W; KRAATZ HG
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1958; 232(3):562-72. PubMed ID: 13552733
    [No Abstract]   [Full Text] [Related]  

  • 22. [2 Years experience with butazolidin].
    BUCHMULLER W
    Medizinische; 1958 Apr; 12(14):569. PubMed ID: 13540797
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antithrombotic effects of butazolidin].
    STAMM H
    Geburtshilfe Frauenheilkd; 1958 Nov; 18(11):1354-60. PubMed ID: 13609888
    [No Abstract]   [Full Text] [Related]  

  • 24. Preliminary clinical report on delta-butazolidin (geigy).
    MORIARTY MA
    J Ir Med Assoc; 1959 Apr; 44(262):114-6. PubMed ID: 13641845
    [No Abstract]   [Full Text] [Related]  

  • 25. [Combined use of butazolidin (phenylbutazone) and some corticosteroids in experimental inflammations].
    WILHELMI G
    Schweiz Med Wochenschr; 1958 Feb; 88(8):185-8. PubMed ID: 13543303
    [No Abstract]   [Full Text] [Related]  

  • 26. The physiological disposition of phenylbutazone (butazolidin) in man and a method for its estimation in biological material.
    BURNS JJ; ROSE RK; CHENKIN T; GOLDMAN A; SCHULERT A; BRODIE BB
    J Pharmacol Exp Ther; 1953 Nov; 109(3):346-57. PubMed ID: 13109696
    [No Abstract]   [Full Text] [Related]  

  • 27. [Preliminary report on evaluation of the liver tolerance of a new antiphlogistic substance (G27, 202)].
    GIGGLBERGER H
    Praxis; 1960 Dec; 49():1233. PubMed ID: 13705198
    [No Abstract]   [Full Text] [Related]  

  • 28. [The osmotic behavior of normal, of inflamed, and of 1,2-diphenyl-4-butyl-3,5-pyrazolidinedione-treated rat liver slices].
    BURCK HC
    Arzneimittelforschung; 1960 Sep; 10():752-5. PubMed ID: 13688929
    [No Abstract]   [Full Text] [Related]  

  • 29. [Experimental studies on influencing antibody formation by butazolidin].
    ROTHER K; KATZ F
    Arch Int Pharmacodyn Ther; 1957 Oct; 112(1-2):65-72. PubMed ID: 13498839
    [No Abstract]   [Full Text] [Related]  

  • 30. [On the thyrostatic effect of phenylbutazone and oxyphenbutazone under the influence of triiodothyronine].
    Eger W; Fernholz J
    Med Pharmacol Exp Int J Exp Med; 1965; 13(1):17-23. PubMed ID: 5898618
    [No Abstract]   [Full Text] [Related]  

  • 31. [Influence of butazolidin on the biosynthesis of thyroid hormones].
    HILLMANN G
    Klin Wochenschr; 1957 Nov; 35(22):1124-6. PubMed ID: 13515150
    [No Abstract]   [Full Text] [Related]  

  • 32. [The significance of the thyroid gland in relation to the inhibition of inflammation by butazolidin].
    STENGER EG
    Arch Int Pharmacodyn Ther; 1959 Sep; 121():297-305. PubMed ID: 13834307
    [No Abstract]   [Full Text] [Related]  

  • 33. The antithyroid effect of phenylbutazone.
    CASTENFORS H; LOVGREN O; ALLGOTH AM
    Acta Rheumatol Scand; 1956; 2(4):244-50. PubMed ID: 13402555
    [No Abstract]   [Full Text] [Related]  

  • 34. [Contribution on the problem of the thyrostatic effect of butazolidin].
    HULLIGER L; WALSER A; LUTHY H
    Schweiz Med Wochenschr; 1960 Nov; 90():1348-9. PubMed ID: 13716755
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.